Matthew Pullen is a Vice Chairman with Newmark in Boston, one of the nation’s most successful investment property sales teams, specializing in the sale of investment grade office, industrial and mixed-use properties across the country. In all, he and his team have sold upwards of $45 billion of office, industrial/flex, retail and multi-family investment properties in the northeast United States. Pullen started his career at CBRE as the Director of Research for New England, authoring the market’s leading research reports. He went on to work as a Senior Vice President at CBRE’s Institutional Group, selling over $1 billion of investment properties before he joined the market leading investment team at Cushman & Wakefield in 2012. In 2014 alone, the team handled the sale of 72 assets valued at over $4.2 billion.
Pullen’s extensive clientele has included some of the region’s most recognized real estate owners including Blackstone, Boston Properties, Clarion, Divco West, Deutsche Bank, JP Morgan, Invesco, Prudential and Skanska, among many others.
An active member of the Urban Land Institute (ULI), Pullen is currently Vice Chair of Membership for its Office Development Council and a member of the advisory board for its Boston District Council; he previously co-chaired the Boston Market Council. Pullen is also a member of the Greater Boston Real Estate Board/Commercial Brokers Association (CBA).
Pullen is a 2000 graduate of the University of Richmond, where he received a Bachelor of Business Administration degree. He resides in Newbury, Massachusetts, with his wife Kim and their two children, Grant and Olivia.
Related Media
04.12.23
In the News
Newmark Facilitates Recapitalization of 15 Necco Street in Boston, Massachusetts
View
04.12.23
Press Release
Newmark Facilitates Recapitalization of 15 Necco Street in Boston, Massachusetts
Newmark has arranged the recapitalization of 15 Necco Street, a 345,995-square-foot Class A life science asset currently being developed in the Seaport District of Boston, Massachusetts.
View
11.09.22
In the News
Developer Of Burlington Lab Conversion Sells Building To MetLife For $103M
View
11.09.22
Press Release
Newmark Completes $103 Million Sale of Burlington BioCenter in Burlington, Massachusetts
Newmark announces the $103 million sale of Burlington BioCenter, a newly delivered life science asset that is located 15 miles northwest of Boston in Burlington, Massachusetts.
View
09.22.22
In the News
FoxRock Properties Acquires 157,229 SF Office Complex in Burlington, Massachusetts
View
08.01.22
Press Release
Newmark Arranges $514 Million in Construction Financing for Phase I of Assembly Innovation Park in Somerville, Massachusetts
Newmark announces the arrangement of $514 million in construction financing for Phase I of Assembly Innovation Park, a 485,000-square-foot life science tower that is under development by BioMed Realty in Somerville, Massachusetts.
View
07.25.22
In the News
Newmark Recaps 300 Third Street in Cambridge; Fourth for Seller Totals $3.2B
View
07.18.22
Press Release
Newmark Completes Recapitalization of 300 Third Street in Cambridge, Massachusetts
Newmark announces the recapitalization of 300 Third Street, a six-story 131,963-square-foot Class A laboratory/office asset located in Cambridge, Massachusetts.
View
07.11.22
In the News
Newmark Completes Sale of 100 Rustcraft Road in Dedham
View
07.11.22
Press Release
Newmark Completes Sale of 100 Rustcraft Road in Dedham, Massachusetts
Newmark announces the sale of 100 Rustcraft Road, a flex, R&D and laboratory asset located in the suburban Boston community of Dedham, Massachusetts.
View
06.09.22
In the News
Newmark Completes $132 Million Sale of One Patriots Park in Bedford
View
06.09.22
Press Release
Newmark Completes $132 Million Sale of One Patriots Park in Bedford, Massachusetts
Newmark announces the $132 million sale of One Patriots Park, a Class A life science asset located in the suburban Boston community of Bedford, Massachusetts
View